PP
ROIV icon

PDT Partners’s Roivant Sciences ROIV Stock Holding History

PDT Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4M Sell
376,509
-88,435
-19% -$2.27M 0.62% 36
2025
Q4 		$10.1M Sell
464,944
-152,518
-25% -$3.01M 0.65% 24
2025
Q3 		$9.34M Sell
617,462
-177,964
-22% -$2.2M 0.59% 27
2025
Q2 		$8.96M Buy
795,426
+226,535
+40% +$2.46M 0.51% 33
2025
Q1 		$5.74M Buy
568,891
+60,460
+12% +$654K 0.41% 48
2024
Q4 		$6.01M Buy
508,431
+109,324
+27% +$1.29M 0.53% 17
2024
Q3 		$4.61M Buy
399,107
+215,000
+117% +$2.45M 0.41% 36
2024
Q2 		$1.95M Buy
184,107
+111,907
+155% +$1.23M 0.18% 207
2024
Q1 		$761K Sell
72,200
-85,494
-54% -$922K 0.07% 384
2023
Q4 		$1.77M Buy
+157,694
New +$1.54M 0.2% 177
2023
Q2 		– Sell
-69,769
Closed -$515K – 639
2023
Q1 		$515K Buy
+69,769
New +$574K 0.07% 385

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PDT Partners's ROIV Position: Q1 2026 in Review

PDT Partners reduced its Roivant Sciences (ROIV) stake by 19% in Q1 2026, selling an estimated $2.27M and leaving 376,509 shares worth $10.4M. The position accounts for 0.62% of the portfolio, ranked #36.

PDT Partners first reported a position in ROIV in Q1 2023 and has held it in 11 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • PDT Partners held 376,509 shares of Roivant Sciences worth $10.4M as of Q1 2026.
  • PDT Partners sold 88,435 Roivant Sciences shares in Q1 2026, an estimated $2.27M.
  • Roivant Sciences made up 0.62% of PDT Partners's portfolio in Q1 2026, its #36 holding.
  • PDT Partners first reported a position in Roivant Sciences in Q1 2023 and has held it in 11 quarters since.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.